Resumo
The Prevention of Mother to Child Transmission (PMTCT) programme in the University College Hospital (UCH), Ibadan has been in existence for more than five years and has scaled up to other sites. The study evaluated the service uptake and performance of the programme using national key indicators. Antenatal and delivery records of women enrolled between July 2002 and June 2007 were reviewed. A total of 51952 women attended first antenatal visits and received HIV pre-test counselling. Of these, 51614 (99.5%) accepted HIV test and 49134 (95.2%) returned for their results. Out of the tested patients, 2152 (4.2%) were identified to be HIV positive. Partners of positive patients accepting HIV testing were 361(16.7%) with 87 (18.6%) testing positive. There were a total of 942 deliveries out of which 39.2% of the mothers and 95.2% of the babies respectively received ARV prophylaxis. In all, 85.8% (788/918) of the mothers opted for formula as the method of infant feeding. Out of the 303 babies eligible for ELISA testing, 68.3% reported for the test and 17(8.7%) tested positive. There has been progress in the programme, reflected in the increase in the number of new clients accessing the PMTCT service. However, partner testing and follow up of mother-infant pairs remain formidable challenges that deserve special attention.
Keywords: PMTCT indicators; uptake; partner testing; caesarean section; infant testing; transmission rate; Nigeria
Résumé
Le programme de prévention de la transmission de la mère a l’enfant au collège hospitalier universitaire (UCH), Ibadan existe depuis plus de 5 ans et s’est étendu dans d’autres sites. L’étude a évalué les services rendus et la performance du programme en utilisant les indicateurs nationaux clés. Les registres de soins prénatales et d’accouchements des femmes enregistrées entre juillet 2002 et juin 2007 étaient revus. Un total de 51952 femmes ont atteints la première visite prénatale et ont reçues des conseils concernant le VIH. De ceux-ci, 51614 (99.5%) ont accepte le test et 49134 (95.2%) ont pris leurs résultats. Des patients testes, 2152 (4.2%) étaient identifies séropositifs. Les partenaires des patients séropositifs qui ont acceptés le test étaient 361 (16.7%) avec 87(18.6%) testes positifs. Il y’avait un total de 942 accouchements, desquels 39.2% des mères et 95.2% des bébés ont reçus l’ARV prophylaxique. En tout, 85,8% (788/918) des mères optèrent pour l’allaitement artificiel. Des 303 bébés éligible aux tests ELISA, 68.3%, reportes pour le test et 17 (8,7%) étaient testes positifs. Il y’a eu des progrès dans le programme, marqué par l’augmentation du nombre de nouveau clients optant pour les services PMTCT. Les tests des partenaires et le suivi de la mère et de l’enfant restent un défi qui mérite des soins particuliers.
Correspondence: Dr. Reginal Oladokun, Paediatrics/APIN-PLUS, University College Hospital, Ibadan. Nigeria. E-mail: ginaoladokun@yahoo,
Referências
UNICEF state of the world’s children 2007. Available at: http://www.sarpn.org.za/documents/d0002250/1-Women_children_2007_Unicef.pdf
De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000; 283(9):1175-1182.
FMOH. National serosurveillance survey for syphilis and HIV 2005 (Nigeria).
Volmink J, Siegfried NL, van der Merwe L and Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD003510. DOI: 10.1002/14651858.CD003510.pub2.
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O’Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs R, Elkins M, Moye Jack, Stratton P and Balsley J. Reduction of maternal infant transmission of human immunodeficiency virus type 1 with Zidovudine treatment. N Engl J Med 1994; 331:1173–1180.
Palombi L, Germano P, Liotta G, Guidootti G, Narcisco P, Perno C F, et al. DREAM Program: 6-month follow-up of the prevention of mother-to-child transmission service. 13th Conference on Retroviruses and Opportunistic Infections, 5-8; Denver (USA); 2006.
Guay LA, Musoke P, Fleming T et al. Intrapartum and neonatal single-dose nevirapine compared with Zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised controlled trial. Lancet 1999:354, 795–802.
Adewole IF, Odutolu O and Sagay AS. Prevention of mother to child transmission of HIV. In: AIDS in Nigeria. A nation on the threshold. Eds. Adeyi O, Kanki PJ, Odutolu O, Idoko JA. Havard center for population and development studies. Cabridge, MA, USA. Pg 349 – 384.
FMOH. National Guidelines on Prevention of mother to child transmission of HIV (PMTCT). 2006
Chandisarewa W, Stranix-Chibanda L, Chirapa E, Miller A, Simoyi M, Mahomva A, Maldonado U and Shetty AK. Routine offer of antenatal HIV testing (“opt-out” approach) to prevent mother-to-child transmission of HIV in urban Zimbabwe. Bulletin of the World Health Organization 2007; 85: 821 – 900.
Perez F, Zvandaziva C, Engelsmann B and Dabis F. Acceptability of routine HIV testing (“opt-out”) in antenatal services in two rural districts of Zimbabwe. J Acquir Immune Defic Syndr 2006; 41(4):514- 520.
Homsy J, Kalamya JN, Obonyo J, Ojwang J, Mugumya R, Opio C, et al. Routine Intrapartum HIV Counselling and Testing for Prevention of Mother-to-Child Transmission of HIV in a Rural Ugandan Hospital. J Acquir Immune Defic Syndr 2006; 42(2):149-154.
Mosesa A, Zimbaa C, Kamangaa E, Nkhomaa J, Maidab A, Martisona F, Mofoloa I, Joakia G, Muitac J, Spensleyd A, Hoffmane I and van der Horste CM. Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi. AIDS 2008, 22:83–88.
N Rutenberg, C Baek, S Kalibala, J Rosen and D Mulenga. Evaluation of United Nations-supported pilot projects for the prevention of mother-to-child transmission of HIV: overview of findings. Med Gen Med 2004: 11;6(3):WePeE6688 [eJIAS. 2004 Jul 11;1(1):WePeE6688]
Shutes E, Vwalika C, Kasonde P, Sinkala M, Kankasa C, Allen S, Aldrovandi G, Kuhn L and Thea DM. Involvement of men in programs to prevent mother-to-child transmission of HIV. Int Conf AIDS. 2002 Jul 7-12; 14: abstract no. MoOrF1032.
Medley A, Garcia-Moreno C, McGill S and Maman S. Rates, Barriers and Outcomes of HIV Serostatus Disclosure among Women in Developing Countries: Implications for Prevention of Mother-to-Child Transmission Programmes. Bull World Health Organ 2004; 82: 299–307.
Kmietowicz A. Women are being let down in efforts to stem HIV/AIDS. BMJ 2004; 328: 305.
Ezechi OC, Fasubaa OB, Kalu BE, Nwokoro C and Obiesie LO. Caesarean delivery: Why the aversion? Trop J Obstet gynaecol 2004: 21 (2); 164 - 167
Kuhn L, Bobat R, Coutsoudis A et al. Caesarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa. J AIDS Hum Retrovirol 1996; 11: 478– 483.
World Health Organization. Antiretroviral drugs for treating pregnant women and prevention of HIV infection in infants: guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Geneva: World Health Organization, 2004.
Eshleman SH, Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving Nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS 2001; 15: 1951-1957.
Adewole IF, Sagay AS, Meloni S, Jolaymi T, Ochigbo S, Awolude AO, Oguche S, Okonkwo P and Kanki P. Rate and predictors of mother-to-child transmission in large antiretroviral scale-up programme in Nigeria. Presented at ICASA Senegal, 2008.
Doherty TM, McCoy D and Donohue S. Health system constraints to optimal coverage of the prevention of mother-to-child HIV transmission programme in South Africa: Lessons from the implementation of the national pilot programme. African Health Sciences 2005; 5(3): 213 – 218.